About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Data Collection With the P200TE and P200TxE | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT05615896

Data Collection With the P200TE and P200TxE

The primary objective is to collect OCT scans on a modified P200TxE and P200TE.

Lead sponsor: Optos, PLC•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Optos, PLC

Age

22 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female volunteers 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed;
•Volunteers who can follow the instructions by the clinical staff at the clinical site;
•Volunteers who agree to participate;
•Volunteers who have been diagnosed with retina pathology with intra-retinal and/or subretinal fluid present in the posterior pole region.

Exclusion Criteria

•Volunteers unable to tolerate ophthalmic imaging;
•Volunteers with ocular media not sufficiently clear to obtain acceptable OCT images.

Related studies

National Eye Institute Biorepository for Retinal Diseases

NCT01496625 · Age-Related Macular Degeneration, Diabetic Retinopathy, and more

The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more

Cell Collection to Study Eye Diseases

NCT01432847 · Retinal Disease, AMD, and more

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease

NCT06380075 · Retinal Disease

RECRUITINGPhase 1/2

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

NCT06789445 · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 12, 2024Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment5

Start dateApr 2021

Last updatedMar 12, 2024

Condition

Retinal Disease

Locations shown

Retina Consultants of Texas Research Centers

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions